Dr. Paolo Vinciguerra Describes the European Experience in Corneal Cross-linking with Riboflavin (CCR) and UVA
Dr. Paolo Vinciguerra Describes the European Experience in Corneal Cross-linking with Riboflavin (CCR) and UVA
Dr. Paolo Vinciguerra explains the current state of the research on CCR (corneal cross-linking with riboflavin + UVA) in an interview with Dr. Carlos Buznego. Dr. Vinciguerra and his team in Italy have conducted several studies to evaluate the immediate and long-term effects of CCR in the treatment of keratoconus patients. Using the latest topography systems (Galilei, Pentacam), wavefront mapping systems, ORA, pachymetry and IOP, it was found that flattening of the cornea was immediate and continued to improve out to two years of follow-up. Post-LASIK ectasia in a patient population of ten eyes, with a 12-month follow up, has shown stabilization of disease and, again, improvement with time. Dr. Vinciguerra describes the optimized treatment procedure in detail; epithelial stripping, pilocarpine, 30 min. riboflavin soak, UVA application (6 x 5 min.), bandage contact lens during re-epithilialization.